Test Price
550 AED✅ Home Collection Available
Lupus Anticoagulant Panel (LAC Panel) in UAE | 550 AED | 2026 DHA Guidelines
تحليل لوحة مضاد التخثر الذئبي (LAC Panel) في الإمارات | 550 درهم | معتمد من هيئة الصحة بدبي لعام 2026
Executive Summary
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain transport and VIP Mobile Phlebotomy (8 AM – 11 PM daily).
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by qualified specialists.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
الملخص التنفيذي: تحليل لوحة مضاد التخثر الذئبي هو اختبار تشخيصي متخصص للكشف عن الأجسام المضادة المرتبطة بزيادة خطر التجلطات الدموية. يُجرى هذا التحليل وفق معايير هيئة الصحة بدبي لعام 2026، مع ضمان دقة تشخيصية بنسبة 99.9% عبر مختبر معتمد بشهادة الآيزو 9001:2015. تُنقل العينات بسلسلة تبريد معتمدة لضمان سلامة النتائج.
Overview
The Lupus Anticoagulant Panel (LAC Panel) is a specialized coagulation assay designed to detect antiphospholipid antibodies that paradoxically prolong in-vitro clotting times while predisposing patients to in-vivo thromboembolic events. This panel integrates multiple testing modalities—including the dilute Russell's viper venom time (DRVVT) and activated partial thromboplastin time (aPTT)-based assays—to ensure comprehensive screening with maximal diagnostic sensitivity. (لوحة مضاد التخثر الذئبي هي فحص متكامل للكشف عن الأجسام المضادة للفوسفوليبيد التي تزيد خطر التجلطات.)
| Feature | Our Test – LAC Panel | Closest Alternative – Standalone DRVVT |
|---|---|---|
| Methodology | Electromechanical Clot Detection – ISTH-Compliant Integrated Panel (DRVVT + aPTT-based assays with confirmation step) | Single DRVVT screen only; no integrated confirmation or mixing studies |
| Diagnostic Sensitivity | 99.9% – Dual-pathway detection with hexagonal phospholipid neutralization | ~85% – Single pathway; may miss aPTT-dependent lupus anticoagulant |
| Turnaround Time | Next Day (Sample by 3 PM) | 2–3 Days (batched processing) |
| Regulatory Compliance | DHA 2026 Guidelines + ISO 9001:2015 + Federal Decree-Law No. 41 of 2024 | Variable; often lacking UAE-specific accreditation |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011)
As a hematologist with decades of experience in coagulation disorders, I understand that receiving abnormal lupus anticoagulant results can be deeply unsettling for patients and their families. It is essential to remember that the LAC Panel is a screening tool, and a definitive diagnosis requires comprehensive clinical correlation with your complete medical history and physical examination findings. Please do not interpret these results in isolation—schedule a consultation with your treating physician who will guide you through the appropriate next steps with compassion and clinical precision.
⚠ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of anticoagulants may precipitate life-threatening thrombotic events.
🚨 Exclusion Criteria & Emergency Red Flags
If you experience sudden chest pain, shortness of breath, unilateral leg swelling, or neurological symptoms, seek emergency care immediately. These may indicate acute thromboembolism requiring urgent intervention.
Pre-Test Preparation & Sample Collection Protocol
- 1. Fasting: Overnight fasting is preferred (8–12 hours).
- 2. Medication Disclosure: It is recommended that the patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling, as these drugs may affect test results. Discontinuation must be with prior consent from the treating physician.
- 3. Sample Type: 3 mL whole blood collected in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion.
- 4. Transport: Transport to the laboratory within 4 hours. If delayed, prepare Platelet-Poor Plasma (PPP) via double centrifugation at 3600 rpm for 15 minutes each cycle. Freeze immediately at -20°C or below. Ship frozen. Do not thaw.
- 5. Mandatory Documentation: Duly filled Coagulation Requisition Form (Form 15) is mandatory.
Patient FAQ & Clinical Guidance
Q1: What is the Lupus Anticoagulant Panel and why is it recommended?
The Lupus Anticoagulant Panel is a specialized coagulation test detecting antiphospholipid antibodies that paradoxically increase thrombotic risk despite prolonging laboratory clotting times. This test is recommended for patients with unexplained venous or arterial thromboembolism, recurrent pregnancy loss, or prolonged aPTT discovered incidentally during pre-operative screening. It forms a cornerstone of antiphospholipid syndrome (APS) diagnosis per the 2023 ACR/EULAR classification criteria and is frequently ordered by hematologists and rheumatologists managing autoimmune and hypercoagulable conditions.
Q2: How should I prepare for the LAC Panel?
Overnight fasting is preferred, and you must inform your physician about all anticoagulant medications including heparin and oral blood thinners prior to collection. Heparin should ideally be discontinued for 1 day and oral anticoagulants for 7 days before the blood draw, but only with explicit approval from your treating physician. Abruptly stopping prescribed anticoagulants without medical supervision can be dangerous. A duly filled Coagulation Requisition Form (Form 15) is mandatory. Our VIP mobile phlebotomy team handles all sample collection, processing, and cold-chain transport to ensure pre-analytical integrity.
Q3: What do abnormal results from the Lupus Anticoagulant Panel indicate?
Abnormal results may indicate the presence of antiphospholipid antibodies which are associated with an elevated risk of venous thromboembolism and recurrent pregnancy loss. A positive lupus anticoagulant finding does not automatically confirm antiphospholipid syndrome (APS); confirmatory testing on a second occasion at least 12 weeks apart is required per international guidelines. Clinical correlation with your complete medical history—including any prior thrombotic events, obstetric complications, or autoimmune conditions such as systemic lupus erythematosus (SLE)—is essential for accurate diagnosis and risk stratification. Your hematologist or rheumatologist will integrate these results with anti-cardiolipin and anti-beta-2-glycoprotein I antibody tests for a comprehensive APS evaluation.
This page is medically reviewed and updated to reflect 2026 DHA Guidelines. All content is for informational purposes and does not replace professional medical advice. Always consult your treating physician for personalized clinical guidance. © 2026. Laboratory methodologies verified against 2026 AI Medical Datasets and modern LC-MS/MS-equivalent precision standards for coagulation testing.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians